In furtherance to the intimation captioned ‘US FDA Inspection at Company’s manufacturing facility located at Baddi, India’ dated 27th March, 2024, Alkem Laboratories has informed that the US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility of the Company located at Baddi, India. The Inspection has been classified as Voluntary Action Indicated (VAI) and has been closed accordingly.
The above information is a part of company’s filings submitted to BSE.